Literature DB >> 11706110

Lewy bodies are not increased in progressive supranuclear palsy compared with normal controls.

Y Tsuboi1, J E Ahlskog, H Apaydin, J E Parisi, D W Dickson.   

Abstract

OBJECTIVE: To determine the frequency of Lewy bodies (LB) in progressive supranuclear palsy (PSP).
BACKGROUND: LB are characteristic of PD, but are also found in normal controls and in other neurodegenerative diseases, especially AD.
METHOD: The authors evaluated the brains of 72 consecutive cases of pathologically confirmed PSP and 98 normal controls, ranging in age from 60 to 100 years, with immunohistochemistry for alpha-synuclein.
RESULTS: LB and Lewy neurites were found in 13 cases of PSP, with the most numerous LB and Lewy neurites in the basal forebrain and amygdala; most cases also had LB in the substantia nigra. The frequency of LB in the substantia nigra (12%) was comparable to the frequency of LB in controls (9%).
CONCLUSIONS: In contrast to increased frequency of LB in AD, there is no apparent interaction between LB and the tau pathology in PSP.

Entities:  

Mesh:

Year:  2001        PMID: 11706110     DOI: 10.1212/wnl.57.9.1675

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  Typical or atypical progressive supranuclear palsy: a comparative clinicopathologic study of three Chinese cases.

Authors:  Ming-Wei Zhu; Jia Liu; Thomas Arzberger; Lu-Ning Wang; Zhen-Fu Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

2.  Lewy body pathology in normal elderly subjects.

Authors:  William R Markesbery; Gregory A Jicha; Huaichen Liu; Frederick A Schmitt
Journal:  J Neuropathol Exp Neurol       Date:  2009-07       Impact factor: 3.685

3.  Increased frequency of alpha-synuclein in the substantia nigra in human immunodeficiency virus infection.

Authors:  Negar Khanlou; David J Moore; Gursharan Chana; Mariana Cherner; Deborah Lazzaretto; Sharron Dawes; Igor Grant; Eliezer Masliah; Ian P Everall
Journal:  J Neurovirol       Date:  2009-04       Impact factor: 2.643

4.  Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy Pathology.

Authors:  Heather B Rigby; Brittany N Dugger; Joseph G Hentz; Charles H Adler; Thomas G Beach; Holly A Shill; Erika Driver-Dunckley; Marwan N Sabbagh; Lucia I Sue; John N Caviness
Journal:  Mov Disord Clin Pract       Date:  2014-10-29

5.  Enhanced Susceptibility of PINK1 Knockout Rats to α-Synuclein Fibrils.

Authors:  Rose B Creed; Matthew S Goldberg
Journal:  Neuroscience       Date:  2020-04-27       Impact factor: 3.590

6.  Midbrain catecholaminergic neurons co-express α-synuclein and tau in progressive supranuclear palsy.

Authors:  María Elena Erro Aguirre; María Victoria Zelaya; Javier Sánchez Ruiz de Gordoa; María Teresa Tuñón; José Luis Lanciego
Journal:  Front Neuroanat       Date:  2015-03-11       Impact factor: 3.856

Review 7.  Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities.

Authors:  Naomi P Visanji; Anthony E Lang; Gabor G Kovacs
Journal:  Transl Neurodegener       Date:  2019-09-04       Impact factor: 8.014

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.